Unither Pharmaceuticals | Unither Pharmaceuticals Nanjing

The manufacturing site is located in China, and forms part of the group’s global network of contract development and manufacturing organizations (CDMOs). The facility specializes in the development and production of pharmaceutical products in both solid and liquid dosage forms, including sterile formulations.

The site has strong expertise in sterile single-dose liquid products manufactured using Blow-Fill-Seal (BFS) technology. This aseptic process integrates container forming, filling, and sealing in a single operation and is widely used for ophthalmic and respiratory solutions requiring high sterility assurance. The facility focuses particularly on ophthalmology and ENT products, supplying pharmaceutical companies in China and supporting access to international markets.

In addition to sterile liquid manufacturing, the plant also supports solid dosage forms and provides development services such as formulation development, process optimization, and analytical quality control testing. Operating under Chinese GMP regulations and aligned with international pharmaceutical quality standards, the facility plays a strategic role in the company expansion in Asia and in supplying safe, high-quality pharmaceutical products to regional and global healthcare markets.